JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B4950 Darunavir Ethanolate

Summary: nonpeptidic HIV protease inhibitor

≥59.17 mg/mL
A8702 Mesoridazine

Summary: A dopaminergic antagonist

insoluble in H2O; ≥16.35 mg/mL
B5998 GSK2801

Summary: inhibitor of BAZ2A and BAZ2B bromodomains

insoluble in H2O; ≥18.55 mg/mL
A5760 KRN 633

Summary: VEGFR inhibitor,ATP-competitive

insoluble in EtOH; insoluble in H2O; ≥13.75 mg/mL
A8335 Palbociclib (PD0332991) Isethionate
1 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK4/6 inhibitor,highly selective

≥28.7 mg/mL
A8437 Gemcitabine
9 Citation

Summary: inhibitor of DNA synthesis

≥11.75 mg/mL
A8600 Tankyrase Inhibitors (TNKS) 22

Summary: Tankyrase inhibitor
B2184 GDC-0980 (RG7422)

Summary: Class I PI3K inhibitor for PI3Kα/β/δ/γ

≥21.35 mg/mL
B1621 TAK-733

Target: MEK

Summary: MEK allosteric site inhibitor

≥25.2 mg/mL
B1303 Amsacrine hydrochloride

Summary: Topoisomerase 2 inhibitor

≥55.56 mg/mL